Pituitary-adrenal function after prolonged use of topical corticosteroids.
D015062:11-Hydroxycorticosteroids / Q000097:blood; D000287:Administration, Topical; D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects*; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D002648:Child; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D007328:Insulin; D008297:Male; D008875:Middle Aged; D010902:Pituitary Gland / Q000187:drug effects*; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D013997:Time Factors
D015062:11-Hydroxycorticosteroids; D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D007328:Insulin; D005446:Fluocinolone Acetonide; D001623:Betamethasone